These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 12065645)

  • 1. PI 3-kinase regulation of dopamine uptake.
    Carvelli L; Morón JA; Kahlig KM; Ferrer JV; Sen N; Lechleiter JD; Leeb-Lundberg LM; Merrill G; Lafer EM; Ballou LM; Shippenberg TS; Javitch JA; Lin RZ; Galli A
    J Neurochem; 2002 May; 81(4):859-69. PubMed ID: 12065645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity.
    Morón JA; Zakharova I; Ferrer JV; Merrill GA; Hope B; Lafer EM; Lin ZC; Wang JB; Javitch JA; Galli A; Shippenberg TS
    J Neurosci; 2003 Sep; 23(24):8480-8. PubMed ID: 13679416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution.
    Garcia BG; Wei Y; Moron JA; Lin RZ; Javitch JA; Galli A
    Mol Pharmacol; 2005 Jul; 68(1):102-9. PubMed ID: 15795321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
    Kahlig KM; Javitch JA; Galli A
    J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism.
    Saunders C; Ferrer JV; Shi L; Chen J; Merrill G; Lamb ME; Leeb-Lundberg LM; Carvelli L; Javitch JA; Galli A
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6850-5. PubMed ID: 10823899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.
    Binda F; Dipace C; Bowton E; Robertson SD; Lute BJ; Fog JU; Zhang M; Sen N; Colbran RJ; Gnegy ME; Gether U; Javitch JA; Erreger K; Galli A
    Mol Pharmacol; 2008 Oct; 74(4):1101-8. PubMed ID: 18617632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes.
    Doolen S; Zahniser NR
    J Pharmacol Exp Ther; 2001 Mar; 296(3):931-8. PubMed ID: 11181926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
    Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
    Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug interactions with the dopamine transporter in cryopreserved human caudate.
    Eshleman AJ; Wolfrum K; Mash DC; Christensen K; Janowsky A
    J Pharmacol Exp Ther; 2001 Feb; 296(2):442-9. PubMed ID: 11160629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons.
    Park SU; Ferrer JV; Javitch JA; Kuhn DM
    J Neurosci; 2002 Jun; 22(11):4399-405. PubMed ID: 12040046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen peroxide induces loss of dopamine transporter activity: a calcium-dependent oxidative mechanism.
    Huang CL; Huang NK; Shyue SK; Chern Y
    J Neurochem; 2003 Sep; 86(5):1247-59. PubMed ID: 12911632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
    Midde NM; Gomez AM; Zhu J
    J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein.
    Chang MY; Lee SH; Kim JH; Lee KH; Kim YS; Son H; Lee YS
    J Neurochem; 2001 May; 77(3):754-61. PubMed ID: 11331404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations.
    Chi L; Reith ME
    J Pharmacol Exp Ther; 2003 Nov; 307(2):729-36. PubMed ID: 12975490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.
    Wilhelm CJ; Johnson RA; Lysko PG; Eshleman AJ; Janowsky A
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.
    Price DA; Sorkin A; Zahniser NR
    Mol Pharmacol; 2009 Oct; 76(4):812-23. PubMed ID: 19628755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation.
    Johnson LA; Furman CA; Zhang M; Guptaroy B; Gnegy ME
    Neuropharmacology; 2005 Nov; 49(6):750-8. PubMed ID: 16212991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.